TESC
Basic information
Region (hg38): 12:117038923-117099479
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TESC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 11 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 11 | 5 | 6 |
Variants in TESC
This is a list of pathogenic ClinVar variants found in the TESC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-117039169-G-A | Benign (Sep 19, 2018) | |||
12-117039175-G-A | Benign (Dec 31, 2019) | |||
12-117046576-C-T | Benign (Dec 31, 2019) | |||
12-117046583-C-T | Likely benign (Apr 30, 2018) | |||
12-117046631-G-A | Benign (Dec 31, 2019) | |||
12-117046646-C-T | Likely benign (Jun 28, 2018) | |||
12-117046796-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
12-117046803-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
12-117046807-G-A | Likely benign (May 31, 2018) | |||
12-117046812-T-C | not specified | Uncertain significance (Sep 12, 2023) | ||
12-117046847-G-T | Benign (Dec 31, 2019) | |||
12-117049071-G-A | Benign (May 12, 2018) | |||
12-117049087-T-A | not specified | Uncertain significance (Mar 14, 2023) | ||
12-117049112-C-G | not specified | Uncertain significance (May 28, 2024) | ||
12-117049119-G-C | not specified | Uncertain significance (Jun 13, 2023) | ||
12-117049119-G-T | Likely benign (Dec 31, 2019) | |||
12-117049125-A-C | not specified | Uncertain significance (Jun 09, 2022) | ||
12-117056820-G-A | Likely benign (May 09, 2018) | |||
12-117056854-T-A | not specified | Uncertain significance (Aug 17, 2022) | ||
12-117075323-C-T | not specified | Uncertain significance (May 27, 2022) | ||
12-117075334-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
12-117099266-G-A | not specified | Uncertain significance (Nov 10, 2022) | ||
12-117099267-A-G | not specified | Uncertain significance (Nov 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TESC | protein_coding | protein_coding | ENST00000335209 | 8 | 60557 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.108 | 0.886 | 125743 | 0 | 3 | 125746 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.25 | 95 | 136 | 0.699 | 0.00000879 | 1411 |
Missense in Polyphen | 16 | 29.841 | 0.53618 | 340 | ||
Synonymous | 0.456 | 49 | 53.2 | 0.920 | 0.00000394 | 371 |
Loss of Function | 2.40 | 4 | 13.6 | 0.295 | 7.29e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000498 | 0.0000462 |
European (Non-Finnish) | 0.0000103 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as an integral cofactor in cell pH regulation by controlling plasma membrane-type Na(+)/H(+) exchange activity. Promotes the maturation, transport, cell surface stability and exchange activity of SLC9A1/NHE1 at the plasma membrane. Promotes the induction of hematopoietic stem cell differentiation toward megakaryocytic lineage. Essential for the coupling of ERK cascade activation with the expression of ETS family genes in megakaryocytic differentiation. Also involved in granulocytic differentiation in a ERK-dependent manner. Inhibits the phosphatase activity of calcineurin. {ECO:0000269|PubMed:17717601, ECO:0000269|PubMed:18321853, ECO:0000269|PubMed:20060826}.;
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.469
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- 0.182
- hipred
- Y
- hipred_score
- 0.638
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.540
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tesc
- Phenotype
Gene ontology
- Biological process
- negative regulation of protein kinase activity;negative regulation of cell population proliferation;positive regulation of gene expression;protein transport;cell differentiation;positive regulation of granulocyte differentiation;positive regulation of sodium:proton antiporter activity;regulation of cell adhesion mediated by integrin;positive regulation of megakaryocyte differentiation;positive regulation of transcription, DNA-templated;protein stabilization;protein maturation;cellular response to retinoic acid;protein localization to plasma membrane
- Cellular component
- ruffle;nucleus;cytoplasm;cytosol;plasma membrane;lamellipodium;ruffle membrane
- Molecular function
- magnesium ion binding;protein kinase inhibitor activity;calcium ion binding;protein binding;phosphatase inhibitor activity;protein homodimerization activity